Inventor
PADIA JANAK KHIMCHAND
US13 patents
⚠️ This page may combine multiple inventors who share the name “PADIA JANAK KHIMCHAND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WARNER LAMBERT CO
7 patentsUS5869665AFeb 9, 1999
Quinazolinone derivatives as cholecystokinin (CCK) ligands
WARNER LAMBERT CO115 citations97
US5756502AMay 26, 1998
Quinazolinone derivatives as cholyecystokinin (CCK) ligands
WARNER LAMBERT CO122 citations97
US5958950ASep 28, 1999
Benzimidazole compounds useful for the treatment of inflammatory disease, atherosclerosis, restenosis or inhibiting lipoxygenase
WARNER LAMBERT CO64 citations96
US5972980AOct 26, 1999
Method for treating and preventing inflammation and atherosclerosis
WARNER LAMBERT CO71 citations93
US6011052AJan 4, 2000
Pyrazolone derivatives as MCP-1 antagonists
WARNER LAMBERT CO40 citations89
US5846942ADec 8, 1998
Cholecystokinin antagonists, their preparation and therapeutic use
WARNER LAMBERT CO5 citations73
US6897213B1May 24, 2005
Heterocycles as cholecystokinin (CCK) ligands
WARNER LAMBERT CO3 citations62
CONVERGENE LLC
3 patentsUS9695179B2Jul 4, 2017
Methods and compositions for inhibition of bromodomain-containing proteins
CONVERGENE LLC22 citations92
US10266536B2Apr 23, 2019
Methods and compositions for inhibition of bromodomain-containing proteins
CONVERGENE LLC2 citations70
US10717739B2Jul 21, 2020
Methods and compositions for inhibition of bromodomain-containing proteins
CONVERGENE LLC0 citations50
SUPERNUS PHARMACEUTICALS INC
3 patentsUS11634415B2Apr 25, 2023
Derivatives of substituted morpholines and uses thereof
SUPERNUS PHARMACEUTICALS INC5 citations85
US12215097B2Feb 4, 2025
Derivatives of substituted morpholines and uses thereof
SUPERNUS PHARMACEUTICALS INC1 citations74
US11919889B2Mar 5, 2024
Derivatives of substituted morpholines and uses thereof
SUPERNUS PHARMACEUTICALS INC1 citations72